Selectively high efficacy of eribulin against high-grade invasive recurrent and/or metastatic squamous cell carcinoma of the head and neck

Patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) have a poor prognosis. Over the past decade, a major development in the first-line treatment of R/M SCCHN was the introduction of cetuximab in combination with platinum plus 5-fluorouracil chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Yutaka, Kitahara, Hiroko, Hirai, Mariko, Tanaka, Akira, Jokaji, Rei, Kobayashi, Kazuhiko, Bou-Gharios, George, Nakamura, Hiroyuki, Kawashiri, Shuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507455/
https://www.ncbi.nlm.nih.gov/pubmed/31186718
http://dx.doi.org/10.3892/ol.2019.10165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507455/
https://www.ncbi.nlm.nih.gov/pubmed/31186718
http://dx.doi.org/10.3892/ol.2019.10165

Ejemplares similares